The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways-Reference-Cited by-同舟云学术

The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways

Published:2023-09-14 Issue:1 Volume:39 Page:
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Ye Yongju¹,Zhou Weimei²,Ren Yuefang³,Lu Jiali³,Chen Aixue⁴,Jin Ruiying⁵,Xuan Feilan⁶

Affiliation:

1. Department of Gynaecology, Lishui Hospital of Traditional Chinese Medicine, Lishui, China

2. Department of Ultrasound, Jiaojiang Maternal and Child Health Hospital, Taizhou, China

3. Department of Gynecology, Huzhou Maternity and Child Health Care Hospital, Huzhou, China

4. Department of Gynecology, Changxing People’s Hospital of Chongming District, Shanghai City, China

5. Department of Gynecology, Jiaojiang Maternal and Child Health Hospital, Taizhou, China

6. Department of Obstetrics and Gynecology, Hangzhou TCM Hospital affiliated to Zhejiang Chinese Medical University, Hangzhou,China

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/09513590.2023.2254848

Reference45 articles.

1. The effect of metformin on homocysteine levels in patients with polycystic ovary syndrome: A systematic review and meta‐analysis

2. Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome

3. Polycystic Ovary Syndrome

4. Prospective Association of Polycystic Ovary Syndrome With Coronary Artery Calcification and Carotid-Intima-Media Thickness

5. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy